– Interim analysis of real-world REFRESH study demonstrated clinically significant efficacy and improvement of EDS for patients who switched from twice-nightly oxybate to once-at-bedtime LUMRYZ – – ...

For more information on SLEEP 2024, please refer to https://www.sleepmeeting.org/ About Vanda Pharmaceuticals Inc. Vanda is a leading global biopharmaceutical company ...

So that you can make it through your day without too much yawning.

Axsome Therapeutics, Inc. announced seven presentations at the SLEEP 2025 conference, including two featured oral sessions focused on its investigational drugs AXS-12 and solriamfetol for central ...

Avadel Pharmaceuticals plc (NASDAQ:AVDL) announced it will present 14 new abstracts, including four oral presentations, at SLEEP 2025, highlighting significant advances for LUMRYZ, its once-at-bedtime ...

A groundbreaking study published in the medical journal Neurology has revealed a critical link between feeling excessively sleepy during daylight hours and a pre-dementia condition known as motoric ...

Excessive sleepiness as we grow older may be a warning sign of dementia, new research says. Image credit: francesco_de_napoli/Getty Images. Dementia is an increasing problem worldwide. More than 55 ...

A large population study of middle-aged adults suggests that habitual coffee drinking may have far less impact on sleep and daytime fatigue than commonly believed, raising new questions about ...

DUBLIN, May 22, 2024 (GLOBE NEWSWIRE) -- Avadel Pharmaceuticals (AVDL) plc , a company focused on transforming medicines to transform lives, announced today it will present 11 posters, and one oral ...